Issue |
Section |
Title |
File |
Vol 54, No 6 (2023) |
Collection of pluripotent stem cell lines |
Transgenic Lines of Human Induced Pluripotent Stem Cells ICGi022-A-6 and ICGi022-A-7 with Doxycycline-Inducible Variants of Programmable Nuclease AsCas12a |
|
Vol 54, No 2 (2023) |
Original study articles |
Chemokine CCL2 Activates Hypoxia Response Factors Regulating Pluripotency and Directed Endothelial Differentiation of Human Pluripotent Stem Cells |
|
Vol 54, No 1 (2023) |
Collection of pluripotent stem cell lines |
Generation of an Induced Pluripotent Stem Cell Line, ICGi043-A, by Reprogramming Peripheral Blood Mononuclear Cells from Parkinson’s Disease Patient with p.G2019S Mutation in LRRK2 Gene |
|
Vol 54, No 1 (2023) |
Collection of pluripotent stem cell lines |
Generation of an Induced Pluripotent Stem Cell Line, ICGi042-A, by Reprogramming Peripheral Blood Mononuclear Cells from Parkinson’s Disease Patient with c.1000G>A Mutation in LRRK2 Gene |
|
Vol 54, No 1 (2023) |
Collection of pluripotent stem cell lines |
An Induced Pluripotent Stem Cell Line (ICGi023-A) Obtained from a Patient with Parkinson’s Disease Associated Polymorphisms in LRRK2 and PINK1 Genes |
|
Vol 54, No 1 (2023) |
Collection of pluripotent stem cell lines |
Generation of Induced Pluripotent Stem Cell Lines ICGi022-A-3, ICGi022-A-4, and ICGi022-A-5 with p.Asn515del Mutation Introduced in MYBPC3 Using CRISPR/Cas9 |
|
Vol 54, No 1 (2023) |
Collection of pluripotent stem cell lines |
Creation of Induced Pluripotent Stem Cells ICGi044-B and ICGi044-C Using Reprogramming of Peripheral Blood Mononuclear Cells of a Patient with Parkinson’s Disease Associated with с.1492T>G Mutation in the GLUD2 Gene |
|